NCT01684462 - The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Cerebral Infarction

Interventions

BIOLOGICAL

Human Serum Albumin 20

Human Serum Albumin 20% 100cc albumin 1.25g/kg up to 100g (500ml) intravenously infused over 4\~8h, commencing within 12 hours of stroke onset

DRUG

0.9 % Normal Saline

Infusion of 100 mL of 0.9% Normal Saline ( equivalent volume of Albumin ) over 4\~8h, commencing within 12 hours of stroke onset

Trial Locations (4)

St. Vincent's hospital, Suwon

Ewha Womans University Mokdong Hospital, Mokdong

Seoul St. Mary's Hospital, Seocho-Gu

Yeoudo St. Mary's hospital, Yeongdeungpo-gu